Cleared Traditional

K913106 - ABBOTT IMX TOXO IGM POSITIVE CONTROL (FDA 510(k) Clearance)

Nov 1991
Decision
140d
Days
Class 2
Risk

K913106 is an FDA 510(k) clearance for the ABBOTT IMX TOXO IGM POSITIVE CONTROL. This device is classified as a Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii (Class II - Special Controls, product code LGD).

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on November 29, 1991, 140 days after receiving the submission on July 12, 1991.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3780.

Submission Details

510(k) Number K913106 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 12, 1991
Decision Date November 29, 1991
Days to Decision 140 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement

Device Classification

Product Code LGD — Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3780